GALILEO CONSULTING GROUP, INC. for CELLECTAR INC
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
-- HR 3276 (American Medical Isotopes Production Act of 2009) -- Work to add findings and modify definitions and evaluation report to include I-131 and Xe-133 as isotopes to be included under new US production program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL RATHBUN | — |
Medicare/Medicaid MMM
-- HR 3200 / previous discussion draft (America's Affordable Health Choices Act) -- Section 1142: Strike section to extend reimbursement for therapeutic radiopharmaceuticals based on hospital specific cost to charge ratio. -- America's Healthy Future Act / previous Finance Committe health care reform discussion papers -- Strike language to extend reimbursement for therapeutic radiopharmaceuticals based on hospital specific cost to charge ratio.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL RATHBUN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.